نتایج جستجو برای: 0248t 039 and lt 11661

تعداد نتایج: 16846227  

2013
A Naselli J Tibaldi A Accogli A Buoncompagni S Viola S Signa P Picco A Ravelli A Martini M Gattorno

Methods Since 2005, 34 SoJIA patients (19 M, 15 F) were treated with anakinra at the staring dose of 1-2 mg/kg/die. Complete response was defined as the absence of systemic and articular manifestations and normal acute phase reactants at follow-up, with anakinra as a monotherapy. Other patients were considered as partial responders (still in anakinra with evidence of disease activity) or non-re...

Journal: :Organic & biomolecular chemistry 2013
Marie-Céline Frantz Erin M Skoda Joshua R Sacher Michael W Epperly Julie P Goff Joel S Greenberger Peter Wipf

JP4-039 is a lead structure in a series of nitroxide conjugates that are capable of accumulating in mitochondria and scavenging reactive oxygen species (ROS). To explore structure-activity relationships (SAR), new analogs with variable nitroxide moieties were prepared. Furthermore, fluorophore-tagged analogs were synthesized and provided the opportunity for visualization in mitochondria. All an...

Journal: :journal of dentistry, tehran university of medical sciences 0
z. dalili s. motevasseli n. karimi nasab h. ghanepour f. abbaspur

statement of problem: condylar hyperplasia of the mandible is a self limiting abnormality which can cause facial asymmetry, temporomandibular joint (tmj) dysfunction and esthetic problems. treatment planning is based on the results of isotope scanning, clinical findings and patient age. single photon emission tomography (spect) is considered to be a sensitive method in the calculation of condyl...

Journal: :Diabetes 2015
Irena A Rebalka Matthew J Raleigh Donna M D'Souza Samantha K Coleman Alexandra N Rebalka Thomas J Hawke

Diabetes impairs the ability to heal cutaneous wounds, leading to hospitalization, amputations, and death. Patients with diabetes experience elevated levels of plasminogen activator inhibitor 1 (PAI-1), regardless of their glycemic control. It has been demonstrated that PAI-1-deficient mice exhibit improved cutaneous wound healing, and that PAI-1 inhibition improves skeletal muscle repair in mi...

Journal: :middle east journal of digestive diseases 0
seyedmohsen dehghani mohammadhadi imanieh naser honar mahmood haghighat behrooz astaneh ali bahador

background: liver transplantation (lt) is now performed as a cure of numerous untreatable pediatric liver diseases. quality of life (qol) can be affected in pediatric patients with lt. many factors are responsible for lower scores of qol. this article aims to detail qol in liver recipients 6 months after lt in children. methods: qol assessed using child health quality-parent form 50 for parents...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2016
Yan Ji Zhen Weng Philip Fish Neha Goyal Mao Luo Samantha P Myears Tammy L Strawn Bysani Chandrasekar Jianbo Wu William P Fay

OBJECTIVE Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor that promotes and inhibits cell migration, plays a complex and important role in adverse vascular remodeling. Little is known about the effects of pharmacological PAI-1 inhibitors, an emerging drug class, on migration of vascular smooth muscle cells (SMCs) and endothelial cells (ECs), crucial mediators of vascular ...

Journal: :In vivo 2010
Michael W Epperly Julie P Goff Song Li Xiang Gao Peter Wipf Tracy Dixon Hong Wang Darcy Franicola Hongmei Shen Jean-Claude M Rwigema Valerian Kagan Mark Bernard Joel S Greenberger

BACKGROUND/AIM this study evaluated esophageal radioprotection by the Gramicidin S (GS) derived-nitroxide, JP4-039, a mitochondrial targeting peptide-isostere covalently-linked to 4-amino-Tempo, delivered in a novel swallowed oil-based (F15) formulation. MATERIALS AND METHODS C57BL/6HNsd female mice received intraesophageal F15 formulation containing JP4-039 (4 mg/ml in 100 microl volumes) 10...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید